Dr. Sajeel A. Chowdhary, MD

Dr. Chowdhary practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Chowdhary's NPI, 1972533685, was assigned on July 5, 2006. Dr. Chowdhary graduated from King Edward Medical University in 1996. Dr. Chowdhary holds Florida license ME86814.

Dr. Chowdhary's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Chowdhary's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. The medical group on file is Tampa General Medical Group (TGMG). Dmand AI also links Dr. Chowdhary to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chowdhary practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chowdhary's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chowdhary is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Chowdhary's licenses on file in 6 states: Florida, Georgia, Tennessee, Texas, Ohio and Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, fibromyalgia and chronic pain, head injury, lower back pain, neck pain and spine problems, neuropathy and vertigo among the conditions Dr. Chowdhary treats.

CMS data shows 306 Medicare services from Dr. Chowdhary across 5 procedure codes in 2024, for 124 Medicare patients. Medicare paid $32,647 for them.

CMS counts 124 Medicare patients who saw Dr. Chowdhary in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chowdhary's median patient age at 64, with 47% women.

In 2024, Dr. Chowdhary wrote 376 Medicare Part D claims for 68 patients. 83% of them were for generic drugs. CMS names the drug for 236 of them, across 9 drugs with 11 or more claims each, at $175,031 in total drug cost. In 2023, CMS named 211 claims across 10 drugs.

Dr. Chowdhary accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chowdhary as offering telehealth.

Dmand AI links 41 papers to Dr. Chowdhary, published from 2006 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Glioma and Glioblastoma. Dr. Chowdhary has published most often in J Neurooncol. Dr. Chowdhary's most frequent co-authors are Renato V. Larocca, MD, Reid C. Thompson, MD and Peter A. Forsyth, MD.

Dmand AI links Dr. Chowdhary to 10 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Brain Neoplasms. Alliance for Clinical Trials in Oncology sponsors the most, 4.

CMS Open Payments shows 279 general payments to Dr. Chowdhary from 62 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 31% of the total. Merck Sharp & Dohme Corporation paid the most, $32,645. It also lists 1 research payment totaling $104 in 2017.

Dr. Chowdhary graduated from King Edward Medical University in 1996.

Dr. Chowdhary is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.